Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Leibold

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Nature|June 20, 2020
Senolytic CAR T cells reverse senescence-associated pathologiesCorina Amor, Judith Feucht, Josef Leibold, et al.
Nature|February 21, 2024
Author Correction: Senolytic CAR T cells reverse senescence-associated pathologiesCorina Amor, Judith Feucht, Josef Leibold, et al.
Nature Medicine|September 14, 2014
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancerRamona Rudalska, Daniel Dauch, Thomas Longerich, et al.
Cell|September 3, 2021
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerMarcus Ruscetti, John P Morris, Riccardo Mezzadra, et al.
Cell|April 3, 2020
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerMarcus Ruscetti, John P Morris, Riccardo Mezzadra, et al.
Science (New York, N.Y.)|December 22, 2018
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combinationMarcus Ruscetti, Josef Leibold, Matthew J Bott, et al.
Nature Materials|February 7, 2018
Quantitative self-assembly prediction yields targeted nanomedicinesYosi Shamay, Janki Shah, Mehtap Işık, et al.
Nature Biotechnology|February 15, 2022
Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variantsFrancisco J Sánchez-Rivera, Bianca J Diaz, Edward R Kastenhuber, et al.
Cancer Discovery|May 8, 2020
Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer MetastasisJosef Leibold, Marcus Ruscetti, Zhen Cao, et al.
Hepatology (Baltimore, Md.)|December 19, 2018
Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular CarcinomaDerek Lee, Iris Ming-Jing Xu, David Kung-Chun Chiu, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Nature|June 20, 2020
Senolytic CAR T cells reverse senescence-associated pathologiesCorina Amor, Judith Feucht, Josef Leibold, et al.
Nature|February 21, 2024
Author Correction: Senolytic CAR T cells reverse senescence-associated pathologiesCorina Amor, Judith Feucht, Josef Leibold, et al.
Nature Medicine|September 14, 2014
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancerRamona Rudalska, Daniel Dauch, Thomas Longerich, et al.
Cell|September 3, 2021
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerMarcus Ruscetti, John P Morris, Riccardo Mezzadra, et al.
Cell|April 3, 2020
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerMarcus Ruscetti, John P Morris, Riccardo Mezzadra, et al.
Science (New York, N.Y.)|December 22, 2018
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combinationMarcus Ruscetti, Josef Leibold, Matthew J Bott, et al.
Nature Materials|February 7, 2018
Quantitative self-assembly prediction yields targeted nanomedicinesYosi Shamay, Janki Shah, Mehtap Işık, et al.
Nature Biotechnology|February 15, 2022
Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variantsFrancisco J Sánchez-Rivera, Bianca J Diaz, Edward R Kastenhuber, et al.
Cancer Discovery|May 8, 2020
Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer MetastasisJosef Leibold, Marcus Ruscetti, Zhen Cao, et al.
Hepatology (Baltimore, Md.)|December 19, 2018
Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular CarcinomaDerek Lee, Iris Ming-Jing Xu, David Kung-Chun Chiu, et al.
Pageof 3